Track the 한국유니온제약 share price and the full management transaction log of the company, a listed equity based in South Korea. Shares trade on KR KR, under the authority of DART (FSS). Operating in the Health Care sector, 한국유니온제약 has recorded 70 insider filings. Market capitalisation: €217bn. The latest transaction was disclosed on 26 May 2026 (Purchase). Among the most active insiders: 안희숙. Every trade is free.
70
Insider Decl.
0
Thresholds
·
8 ops.
Buy Volume
·
6 ops.
Sell Volume
22Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 23,812 of 25,750 companies
19.3
score / 100
Value
25
Quality
14
FCF yld-0.6%
Earn yld-14%
EV/EBITDA·
ROE·
Gross mgn22%
Net mgn-85%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.